位置:首页 > 蛋白库 > GTR9_MOUSE
GTR9_MOUSE
ID   GTR9_MOUSE              Reviewed;         538 AA.
AC   Q3T9X0; A0A0J9YUW8; B7ZNE4; B9EHN5; D3Z1X2; D6REU9; Q5ERC7; Q7TSK9; Q7TSP0;
AC   Q8BZR3; Q99JJ2;
DT   03-JUL-2019, integrated into UniProtKB/Swiss-Prot.
DT   11-OCT-2005, sequence version 1.
DT   03-AUG-2022, entry version 146.
DE   RecName: Full=Solute carrier family 2, facilitated glucose transporter member 9 {ECO:0000305};
DE   AltName: Full=Glucose transporter type 9 {ECO:0000303|PubMed:16141072};
DE            Short=GLUT-9 {ECO:0000303|PubMed:16141072};
DE   AltName: Full=Urate transporter {ECO:0000305};
GN   Name=Slc2a9 {ECO:0000312|MGI:MGI:2152844};
GN   Synonyms=Glut9 {ECO:0000303|PubMed:16141072};
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1; 2 AND 3), SUBCELLULAR LOCATION,
RP   TISSUE SPECIFICITY, GLYCOSYLATION, AND MUTAGENESIS OF ASN-71.
RX   PubMed=16293642; DOI=10.1210/me.2005-0010;
RA   Keembiyehetty C., Augustin R., Carayannopoulos M.O., Steer S.,
RA   Manolescu A., Cheeseman C.I., Moley K.H.;
RT   "Mouse glucose transporter 9 splice variants are expressed in adult liver
RT   and kidney and are up-regulated in diabetes.";
RL   Mol. Endocrinol. 20:686-697(2006).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=NOD; TISSUE=Spleen;
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J.,
RA   Wilming L.G., Aidinis V., Allen J.E., Ambesi-Impiombato A., Apweiler R.,
RA   Aturaliya R.N., Bailey T.L., Bansal M., Baxter L., Beisel K.W., Bersano T.,
RA   Bono H., Chalk A.M., Chiu K.P., Choudhary V., Christoffels A.,
RA   Clutterbuck D.R., Crowe M.L., Dalla E., Dalrymple B.P., de Bono B.,
RA   Della Gatta G., di Bernardo D., Down T., Engstrom P., Fagiolini M.,
RA   Faulkner G., Fletcher C.F., Fukushima T., Furuno M., Futaki S.,
RA   Gariboldi M., Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N., Hill D.,
RA   Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T., Jakt M.,
RA   Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H., Kitano H.,
RA   Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K., Kurochkin I.V.,
RA   Lareau L.F., Lazarevic D., Lipovich L., Liu J., Liuni S., McWilliam S.,
RA   Madan Babu M., Madera M., Marchionni L., Matsuda H., Matsuzawa S., Miki H.,
RA   Mignone F., Miyake S., Morris K., Mottagui-Tabar S., Mulder N., Nakano N.,
RA   Nakauchi H., Ng P., Nilsson R., Nishiguchi S., Nishikawa S., Nori F.,
RA   Ohara O., Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G.,
RA   Pesole G., Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z.,
RA   Ringwald M., Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B., Sperling S.,
RA   Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K., Tammoja K.,
RA   Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A., Ueda H.R.,
RA   van Nimwegen E., Verardo R., Wei C.L., Yagi K., Yamanishi H.,
RA   Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C., Grimmond S.M.,
RA   Teasdale R.D., Liu E.T., Brusic V., Quackenbush J., Wahlestedt C.,
RA   Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y., Fukuda S.,
RA   Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T., Iida J., Imamura K.,
RA   Itoh M., Kato T., Kawaji H., Kawagashira N., Kawashima T., Kojima M.,
RA   Kondo S., Konno H., Nakano K., Ninomiya N., Nishio T., Okada M., Plessy C.,
RA   Shibata K., Shiraki T., Suzuki S., Tagami M., Waki K., Watahiki A.,
RA   Okamura-Oho Y., Suzuki H., Kawai J., Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=C57BL/6J;
RX   PubMed=19468303; DOI=10.1371/journal.pbio.1000112;
RA   Church D.M., Goodstadt L., Hillier L.W., Zody M.C., Goldstein S., She X.,
RA   Bult C.J., Agarwala R., Cherry J.L., DiCuccio M., Hlavina W., Kapustin Y.,
RA   Meric P., Maglott D., Birtle Z., Marques A.C., Graves T., Zhou S.,
RA   Teague B., Potamousis K., Churas C., Place M., Herschleb J., Runnheim R.,
RA   Forrest D., Amos-Landgraf J., Schwartz D.C., Cheng Z., Lindblad-Toh K.,
RA   Eichler E.E., Ponting C.P.;
RT   "Lineage-specific biology revealed by a finished genome assembly of the
RT   mouse.";
RL   PLoS Biol. 7:E1000112-E1000112(2009).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Adams M.D., Myers E.W., Smith H.O., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2 AND 4).
RC   STRAIN=FVB/N; TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   FUNCTION.
RX   PubMed=18842065; DOI=10.1371/journal.pmed.0050197;
RA   Caulfield M.J., Munroe P.B., O'Neill D., Witkowska K., Charchar F.J.,
RA   Doblado M., Evans S., Eyheramendy S., Onipinla A., Howard P.,
RA   Shaw-Hawkins S., Dobson R.J., Wallace C., Newhouse S.J., Brown M.,
RA   Connell J.M., Dominiczak A., Farrall M., Lathrop G.M., Samani N.J.,
RA   Kumari M., Marmot M., Brunner E., Chambers J., Elliott P., Kooner J.,
RA   Laan M., Org E., Veldre G., Viigimaa M., Cappuccio F.P., Ji C., Iacone R.,
RA   Strazzullo P., Moley K.H., Cheeseman C.;
RT   "SLC2A9 is a high-capacity urate transporter in humans.";
RL   PLoS Med. 5:e197-e197(2008).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
RT   "A tissue-specific atlas of mouse protein phosphorylation and expression.";
RL   Cell 143:1174-1189(2010).
RN   [8]
RP   FUNCTION, TRANSPORTER ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES, AND TISSUE
RP   SPECIFICITY.
RX   PubMed=19587147; DOI=10.1152/ajprenal.00139.2009;
RA   Bibert S., Hess S.K., Firsov D., Thorens B., Geering K., Horisberger J.D.,
RA   Bonny O.;
RT   "Mouse GLUT9: evidences for a urate uniporter.";
RL   Am. J. Physiol. 297:F612-F619(2009).
RN   [9]
RP   FUNCTION, SUBCELLULAR LOCATION, TISSUE SPECIFICITY, AND DISRUPTION
RP   PHENOTYPE.
RX   PubMed=25100214; DOI=10.1038/ncomms5642;
RA   DeBosch B.J., Kluth O., Fujiwara H., Schuermann A., Moley K.;
RT   "Early-onset metabolic syndrome in mice lacking the intestinal uric acid
RT   transporter SLC2A9.";
RL   Nat. Commun. 5:4642-4642(2014).
CC   -!- FUNCTION: High-capacity urate transporter, which may play a role in the
CC       urate reabsorption by proximal tubules. May have a residual high-
CC       affinity, low-capacity glucose and fructose transporter activity.
CC       Transports urate at rates 45- to 60-fold faster than glucose. Does not
CC       transport galactose. May mediate small uptake of adenine but not of
CC       other nucleobases. {ECO:0000250|UniProtKB:Q9NRM0}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=urate(out) = urate(in); Xref=Rhea:RHEA:60368,
CC         ChEBI:CHEBI:17775; Evidence={ECO:0000269|PubMed:19587147};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=649 uM for urate {ECO:0000269|PubMed:19587147};
CC   -!- SUBCELLULAR LOCATION: Basolateral cell membrane
CC       {ECO:0000269|PubMed:16293642, ECO:0000269|PubMed:25100214}; Multi-pass
CC       membrane protein {ECO:0000255}. Apical cell membrane
CC       {ECO:0000269|PubMed:25100214}; Multi-pass membrane protein
CC       {ECO:0000255}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1; Synonyms=GLUT9a {ECO:0000303|PubMed:16293642,
CC       ECO:0000303|PubMed:18842065};
CC         IsoId=Q3T9X0-1; Sequence=Displayed;
CC       Name=2; Synonyms=GLUT9b {ECO:0000303|PubMed:16293642,
CC       ECO:0000303|PubMed:18842065};
CC         IsoId=Q3T9X0-2; Sequence=VSP_060215;
CC       Name=3; Synonyms=GLUT9Sa {ECO:0000303|PubMed:16293642};
CC         IsoId=Q3T9X0-3; Sequence=VSP_060216;
CC       Name=4; Synonyms=GLUT9Sb {ECO:0000303|PubMed:16293642};
CC         IsoId=Q3T9X0-4; Sequence=VSP_060215, VSP_060216;
CC   -!- TISSUE SPECIFICITY: Highly expressed in the intestine, with high
CC       expression in the jejunum and ileum, the segments of the intestine that
CC       perform the majority of urate excretion (PubMed:25100214). Isoform 1:
CC       Widely expressed (PubMed:16293642). Isoform 1: In kidney, expressed at
CC       low levels in proximal tubules (PubMed:19587147). Isoform 2: Primarily
CC       expressed in liver and kidney; with specific expression in distal
CC       convoluted and connecting tubules of kidney (PubMed:16293642,
CC       PubMed:19587147). {ECO:0000269|PubMed:16293642,
CC       ECO:0000269|PubMed:19587147, ECO:0000269|PubMed:25100214}.
CC   -!- PTM: N-glycosylated. {ECO:0000269|PubMed:16293642}.
CC   -!- DISRUPTION PHENOTYPE: Conditional knockout mice lacking Slc2a9 in
CC       enterocytes are born at the expected Mendelian rate; they show no
CC       obvious phenotype and are fertile (PubMed:25100214). Mice however
CC       develop impaired enterocyte uric acid transport kinetics,
CC       hyperuricaemia, hyperuricosuria, spontaneous hypertension,
CC       dyslipidaemia and elevated body fat (PubMed:25100214).
CC       {ECO:0000269|PubMed:25100214}.
CC   -!- SIMILARITY: Belongs to the major facilitator superfamily. Sugar
CC       transporter (TC 2.A.1.1) family. {ECO:0000305}.
CC   -!- CAUTION: High-capacity urate transporter that was first described as a
CC       fructose and glucose transporter. Also described in the literature as
CC       high-affinity and low-capacity glucose and fructose transporter (By
CC       similarity). However, another group could not confirm transporter
CC       activity for glucose or fructose (By similarity).
CC       {ECO:0000250|UniProtKB:Q9NRM0}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF490463; AAP44162.1; -; mRNA.
DR   EMBL; AF469480; AAP47095.1; -; mRNA.
DR   EMBL; AY776155; AAW78908.1; -; mRNA.
DR   EMBL; AK033725; BAC28448.1; -; mRNA.
DR   EMBL; AK156740; BAE33832.1; -; mRNA.
DR   EMBL; AK172234; BAE42900.1; -; mRNA.
DR   EMBL; AC084071; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC171271; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH466524; EDL37556.1; -; Genomic_DNA.
DR   EMBL; BC006076; AAH06076.1; -; mRNA.
DR   EMBL; BC138213; AAI38214.1; -; mRNA.
DR   EMBL; BC145198; AAI45199.1; -; mRNA.
DR   CCDS; CCDS19256.1; -. [Q3T9X0-4]
DR   CCDS; CCDS51482.1; -. [Q3T9X0-3]
DR   CCDS; CCDS51483.1; -. [Q3T9X0-1]
DR   CCDS; CCDS51484.1; -. [Q3T9X0-2]
DR   RefSeq; NP_001012363.2; NM_001012363.2. [Q3T9X0-2]
DR   RefSeq; NP_001095884.1; NM_001102414.1. [Q3T9X0-1]
DR   RefSeq; NP_001095885.1; NM_001102415.1. [Q3T9X0-3]
DR   RefSeq; NP_663534.1; NM_145559.2. [Q3T9X0-4]
DR   RefSeq; XP_006503746.1; XM_006503683.3. [Q3T9X0-2]
DR   RefSeq; XP_006503747.1; XM_006503684.3. [Q3T9X0-2]
DR   RefSeq; XP_006503748.1; XM_006503685.3. [Q3T9X0-2]
DR   RefSeq; XP_006503749.1; XM_006503686.3. [Q3T9X0-4]
DR   RefSeq; XP_006503750.1; XM_006503687.3. [Q3T9X0-4]
DR   RefSeq; XP_011238990.1; XM_011240688.2.
DR   RefSeq; XP_011238991.1; XM_011240689.2. [Q3T9X0-2]
DR   RefSeq; XP_011238992.1; XM_011240690.1. [Q3T9X0-2]
DR   AlphaFoldDB; Q3T9X0; -.
DR   SMR; Q3T9X0; -.
DR   STRING; 10090.ENSMUSP00000063352; -.
DR   TCDB; 2.A.1.1.47; the major facilitator superfamily (mfs).
DR   GlyGen; Q3T9X0; 2 sites.
DR   iPTMnet; Q3T9X0; -.
DR   PhosphoSitePlus; Q3T9X0; -.
DR   jPOST; Q3T9X0; -.
DR   MaxQB; Q3T9X0; -.
DR   PaxDb; Q3T9X0; -.
DR   PRIDE; Q3T9X0; -.
DR   ProteomicsDB; 308426; -.
DR   ProteomicsDB; 312849; -.
DR   ProteomicsDB; 320503; -.
DR   ProteomicsDB; 326260; -.
DR   ProteomicsDB; 330641; -. [Q3T9X0-1]
DR   ProteomicsDB; 335133; -.
DR   ProteomicsDB; 341277; -.
DR   Antibodypedia; 22860; 308 antibodies from 25 providers.
DR   DNASU; 117591; -.
DR   Ensembl; ENSMUST00000005238; ENSMUSP00000005238; ENSMUSG00000005107. [Q3T9X0-4]
DR   Ensembl; ENSMUST00000067872; ENSMUSP00000066872; ENSMUSG00000005107. [Q3T9X0-2]
DR   Ensembl; ENSMUST00000067886; ENSMUSP00000063352; ENSMUSG00000005107. [Q3T9X0-1]
DR   Ensembl; ENSMUST00000129099; ENSMUSP00000122723; ENSMUSG00000005107. [Q3T9X0-2]
DR   Ensembl; ENSMUST00000143758; ENSMUSP00000118430; ENSMUSG00000005107. [Q3T9X0-3]
DR   Ensembl; ENSMUST00000155634; ENSMUSP00000116354; ENSMUSG00000005107. [Q3T9X0-2]
DR   GeneID; 117591; -.
DR   KEGG; mmu:117591; -.
DR   UCSC; uc008xgo.1; mouse. [Q3T9X0-1]
DR   UCSC; uc008xgp.1; mouse.
DR   UCSC; uc008xgq.1; mouse.
DR   UCSC; uc008xgr.1; mouse.
DR   CTD; 56606; -.
DR   MGI; MGI:2152844; Slc2a9.
DR   VEuPathDB; HostDB:ENSMUSG00000005107; -.
DR   eggNOG; KOG0569; Eukaryota.
DR   GeneTree; ENSGT00940000159192; -.
DR   HOGENOM; CLU_001265_28_0_1; -.
DR   InParanoid; Q3T9X0; -.
DR   OMA; MYQSEST; -.
DR   OrthoDB; 326501at2759; -.
DR   PhylomeDB; Q3T9X0; -.
DR   TreeFam; TF313762; -.
DR   Reactome; R-MMU-189200; Cellular hexose transport.
DR   BioGRID-ORCS; 117591; 0 hits in 74 CRISPR screens.
DR   ChiTaRS; Slc2a9; mouse.
DR   PRO; PR:Q3T9X0; -.
DR   Proteomes; UP000000589; Chromosome 5.
DR   RNAct; Q3T9X0; protein.
DR   Bgee; ENSMUSG00000005107; Expressed in small intestine Peyer's patch and 81 other tissues.
DR   ExpressionAtlas; Q3T9X0; baseline and differential.
DR   GO; GO:0016324; C:apical plasma membrane; IDA:UniProtKB.
DR   GO; GO:0016323; C:basolateral plasma membrane; IDA:UniProtKB.
DR   GO; GO:0005887; C:integral component of plasma membrane; IBA:GO_Central.
DR   GO; GO:0016020; C:membrane; IBA:GO_Central.
DR   GO; GO:0005886; C:plasma membrane; IDA:MGI.
DR   GO; GO:0005353; F:fructose transmembrane transporter activity; ISO:MGI.
DR   GO; GO:0005355; F:glucose transmembrane transporter activity; IDA:MGI.
DR   GO; GO:0015149; F:hexose transmembrane transporter activity; IBA:GO_Central.
DR   GO; GO:0015143; F:urate transmembrane transporter activity; IDA:UniProtKB.
DR   GO; GO:0015755; P:fructose transmembrane transport; ISO:MGI.
DR   GO; GO:1904659; P:glucose transmembrane transport; IDA:MGI.
DR   GO; GO:0015749; P:monosaccharide transmembrane transport; IBA:GO_Central.
DR   GO; GO:0046415; P:urate metabolic process; ISO:MGI.
DR   GO; GO:0015747; P:urate transport; IDA:UniProtKB.
DR   Gene3D; 1.20.1250.20; -; 1.
DR   InterPro; IPR045263; GLUT.
DR   InterPro; IPR020846; MFS_dom.
DR   InterPro; IPR005828; MFS_sugar_transport-like.
DR   InterPro; IPR036259; MFS_trans_sf.
DR   InterPro; IPR003663; Sugar/inositol_transpt.
DR   InterPro; IPR005829; Sugar_transporter_CS.
DR   PANTHER; PTHR23503; PTHR23503; 1.
DR   Pfam; PF00083; Sugar_tr; 1.
DR   PRINTS; PR00171; SUGRTRNSPORT.
DR   SUPFAM; SSF103473; SSF103473; 1.
DR   TIGRFAMs; TIGR00879; SP; 1.
DR   PROSITE; PS50850; MFS; 1.
DR   PROSITE; PS00216; SUGAR_TRANSPORT_1; 1.
DR   PROSITE; PS00217; SUGAR_TRANSPORT_2; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell membrane; Glycoprotein; Membrane;
KW   Phosphoprotein; Reference proteome; Transmembrane; Transmembrane helix.
FT   CHAIN           1..538
FT                   /note="Solute carrier family 2, facilitated glucose
FT                   transporter member 9"
FT                   /id="PRO_0000447626"
FT   TOPO_DOM        1..34
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        35..54
FT                   /note="Helical; Name=1"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        55..88
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        89..109
FT                   /note="Helical; Name=1"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        110..120
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        121..143
FT                   /note="Helical; Name=1"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        144..148
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        149..170
FT                   /note="Helical; Name=1"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        171..181
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        182..200
FT                   /note="Helical; Name=1"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        201..211
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        212..233
FT                   /note="Helical; Name=1"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        234..297
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        298..319
FT                   /note="Helical; Name=1"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        320..333
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        334..356
FT                   /note="Helical; Name=1"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        357..362
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        363..385
FT                   /note="Helical; Name=1"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        386..390
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        391..418
FT                   /note="Helical; Name=1"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        419..429
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        430..453
FT                   /note="Helical; Name=1"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        454..458
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        459..480
FT                   /note="Helical; Name=1"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        481..538
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   REGION          495..538
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        513..538
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         3
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9NRM0"
FT   CARBOHYD        55
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        71
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   VAR_SEQ         1..31
FT                   /note="MDSRELALASLMCDTGGPGELSVGHQQRRTK -> MKLSEKNSAETKESQR
FT                   (in isoform 2 and isoform 4)"
FT                   /id="VSP_060215"
FT   VAR_SEQ         208..315
FT                   /note="RESTWPYLFGVIIVPALVQLASLPFLPESPRYLLFEKHDEAGAMKAFQTFLG
FT                   KADVSQELEEALAESRVQRNLRLVSVLELLRAPFVRWQVITVIITMASYQLCGLNA ->
FT                   R (in isoform 3 and isoform 4)"
FT                   /id="VSP_060216"
FT   MUTAGEN         71
FT                   /note="N->Q: Decreased N-glycosylation."
FT                   /evidence="ECO:0000269|PubMed:16293642"
FT   CONFLICT        131
FT                   /note="S -> A (in Ref. 5; AAI45199)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        261
FT                   /note="A -> T (in Ref. 5; AAI45199)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        362
FT                   /note="R -> G (in Ref. 1; AAW78908/AAP47095)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   538 AA;  58621 MW;  BC939DEFF6C79438 CRC64;
     MDSRELALAS LMCDTGGPGE LSVGHQQRRT KKWSFSLVVA ALVGAFGSSF LYGYNLSVVN
     APTPYIKAFY NGTWYRRHGQ PIDPDTLTLL WSVTVSIFAI GGLVGTLMVK MIGKFLGRKS
     TLLVNNGFAI SAALLMACSL RAGTFEMLIV GRFIMGVDGG IALSALPMYL NEISPKEIRG
     SLGQVTAIFI CIGVFSGQLL GLPELLGRES TWPYLFGVII VPALVQLASL PFLPESPRYL
     LFEKHDEAGA MKAFQTFLGK ADVSQELEEA LAESRVQRNL RLVSVLELLR APFVRWQVIT
     VIITMASYQL CGLNAIWFYT NSIFGKAGIP QDKIPYITLS TGGIETLAAI FSGLVIERLG
     RRPLLIGGFG LMALFFGTLT ATLTLQDQAP WVPYLSIVCI LAIIASFCSG PGGIPFILTG
     EFFQQSERPA AFMIAGTVNW LSNFAVGLLF PFIQKSLDSY CFLVFATICI AGATYFYFVL
     PETKNRTHAE ISQAFAKRNK AQPPEVKADS AMTEEKANSQ TEPDSSSTLD SYGQNKIV
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024